Single-dose azithromycin for the treatment of children with acute otitis media

Expert Review of Anti-Infective Therapy

Volumn 3, Issue 5, 2005, Pages 707-717

  Soley, Carolina A ^a   Arguedas, Adriano ^a  

^a Instituto de Atencion Pediatrica Costa Rica   (Costa Rica)

Author keywords

Azithromycin; Children; Otitis media

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTRIAXONE; MACROLIDE; PENICILLIN G; PLACEBO; STREPTOCOCCUS VACCINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILDHOOD DISEASE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; ERADICATION THERAPY; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTITIS MEDIA; OTOSCOPY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RELAPSE; RETREATMENT; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE; TREATMENT OUTCOME; TYMPANOMETRY; VOMITING;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; DRUG ADMINISTRATION SCHEDULE; HUMANS; OTITIS MEDIA;

EID: 27544512114     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.3.5.707     Document Type: Article

References (50)

1. Klein JO. Otitis media. Clin. Infect. Dis. 19, 823-833 (1994).
2. Schappert SM. Office visits for otitis media: United States, 1975-90. Adv. Data 214, 1-19 (1992).
3. Teele DW, Mein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160, 83-94 (1989).
4. Shireman TI, Kelsey KA. Prescribing patterns and retreatment rates in patients with otitis media. Clin. Drug Invest. 22, 303-311 (2002).
5. Block SL, Hedrick J, Tyler RD, Smith RA, Harrison CJ. Microbiology of acute otitis media recently treated with aminopenicillins. Pediatr. Infect. Dis. J. 20, 1017-1021 (2001).
6. Arguedas A, Loaiza C, Perez A et al. Microbiology of acute otitis media in Costa Rican children. Pediatr. Infect. Dis. J. 17, 680-689 (1998).
7. American Academy of Pediatrics, American Academy of Family Physicians, subcommittee on management of acute otitis media. Diagnosis and management of acute otitis media. Pediatrics 113, 1451-1465 (2004).
8. Piglansky L, Leibovitz E, Raiz S et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr. Infect. Dis. J. 22, 405-413 (2003).
9. Dowell SF, Marcy MS, Phillips WR, Gerber MA, Schwartz B. Otitis media - principles of judicious use of antimicrobial agents. Pediatrics 101, 165-171 (1998).
10. Roger G, Carles F, Pangon B et al. Management of acute otitis media caused by resistant pneumococci in infants. Pediatr. Infect. Dis. J. 17, 631-638 (1998).
11. Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect. Dis. 2, 593-604 (2002).
12. Dowell SF, Butler JC, Giebink GS et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr. Infect. Dis. J. 18, 1-9 (1999).
13. Girard AD, Girard D, English AR et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents Chemother. 32, 1948-1954 (1987).
14. Thornsberry C, Ogilvie PT, Holley HP Jr, Sahm DF. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study. Antimicroh. Agents Chemother. 43, 2612-2623 (1999).
15. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A), 73-82 (1990).
16. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J. Antimicrob. Cbemother. 31 (Suppl. E), 39-50 (1993).
17. Rothermel CD. Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale. Curr. Ther. Res. 64(Suppl. A), A4-A15 (2003).
18. Gordon EM, Blumer JL. Rationale for single and high dose treatment regimens with azithromycin. Pediatr. Infect. Dis. J. 23, S102-S107 (2004).
19. Girard AD, Cimochowski CR, Faiella JA. The comparative activity of azithromycin, macrolides and amoxicillin against streptococci in experimental infections. J. Antimicrob. Chemother. 31 (Suppl. E), 29-37 (1993).
20. Girard D, Finegan SM, Cimochowski CR et al. Accelerated dosing of azithromycin in preclinical infection models. 102nd General Meeting of the American Society for Microbiology. UT, USA (2002).
21. Babl FE, Pelton SI, Li Z. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. Antimicrob. Agents Chemother. 46, 2194-2199 (2002).
22. Pukander J, Rautianen M. Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. J. Antimicrob. Chemother. 37(Suppl. C), 53-61 (1996).
23. Dagan R, Leibovitz E, Fliss DM et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob. Agents Chemother. 44, 43-50 (2000).
24. Scaglioni F, Demartini G, Dugnani S, Arcidiacono MM, Pintucci JP, Fraschini F. Interpretation of middle-ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin. J. Clin. Pharmacol. 47, 167-271 (1999).
25. Arguedas A, Dagan R, Soley C et al. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr. Infect. Dis. J. 22, 1063-1068 (2003).
26. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr. Infect. Dis. J. 19, S47-S56 (2000).
27. Hyde TB, Gey K, Stephens DS et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. J. Am. Med. Assoc. 286, 1857-1862 (2001).
28. B phenotypes. Pediatr. Infect. Dis. J. 22, 623-627 (2003).
29. Black S, Shinefield H, Baxter R et al. Postlicensure surveillance of pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in northern California Kaiser Permanente. Pediatr. Infect. Dis. J. 23, 485-489 (2004).
30. Doern GV, Richter SS, Miller A et al. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin. Infect. Dis. J. 41, 139-148 (2005).
31. Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R. Acute otitis media caused by Streptococcus pyogenes in children. Clin. Infect. Dis. J. 41, 35-41 (2005).
32. Reinert R, Lütticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob. Agents Chemother. 47, 489-493 (2003).
33. Perez-Trallero E, Fernandez-Mazarrasa C, Garcia-Rey C et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1 year (1998-1999) multicenter suveillance study in Spain. Antimicrob. Agents Chemother. 45, 3334-3340 (2001).
34. Arguedas A, Loaiza C, Herrera ML, Mohs E. Comparative trial of three days azithromycin versus ten days of amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion. Int. J. Antimicrob. Agents 6, 233-238 (1996).
35. Arguedas A, Loaiza C, Herrera ML, Mohs E. Comparative trial of three days azithromycin versus ten days clarithromycin in the treatment of children with acute otitis media with effusion. J. Chemother. 9, 44-50 (1997).
36. McLinn S. A multicenter, double-blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. Pediatr. Infect. Dis. J. 15, S20-S23 (1996).
37. Principi N. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. Eur. J. Clin. Microbiol. Infect. Dis. 14, 669-676 (1995).
38. Khurana CM. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. Pediatr. Infect. Dis. J. 15(9 Suppl.), S24-S29 (1996).
39. Arguedas A, Loaiza C, Perez A, Gutierrez A, Herrera ML, Rothermel CD. A pilot study of single-dose azithromycin versus 3-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in children. Curr. Ther. Res. 64(Suppl. A), A16-A29 (2003).
40. Dunne MW, Khurana C, Arguedas A et al. Efficacy of single dose azithromycin in the treatment of acute otitis media in children receiving a baseline tympanocentesis. Antimicrob. Agents Chemother. 47, 2663-2665 (2003).
41. Block, SL, Arrieta A, Seibel M, McLinn S, Eppes S, Murphy MJ. Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media. Curr. Ther. Res. 64(Suppl. A), A30-A42 (2003).
42. Arguedas A, Emparanza P, Schwartz R et al. A randomized, multicenter, double-blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pedriatr. Infect. Dis. J. 24, 153-161 (2005).
43. US Department of Health and Human Services. Guidance for Industry, Acute Otitis Media - Developing Antimicrobial Drugs for Treatment. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), WA, USA (1998).
44. Arguedas A, Jorgensen D, Soley C, Dunne M. Single dose (SD) azithromycin (AZM) for treatment (TX) of acute otitis media (AOM) in children <2 years of age. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. IL, USA (2003).
45. Arrieta A, Arguedas A, Fernandez P et al. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob. Agents Chemother. 47, 3179-3186 (2003).
46. Quach C, Moore DL, Collet JP, Lelorier J. Antibiotic utilization and outcomes in the treatment of recurrent acute otitis media in children. 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. IL, USA (2003).
47. Leibovitz E, Jacobs M, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr. Infect. Dis. J. 23(12), 1142-1152 (2004).
48. Dagan R, Johnson C, Mclinn S et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19, 95-104 (2000).
49. Hoberman A, Dagan R, Leibovitz E et al. Large dose amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr. Infect. Dis. J. 24, 525-532 (2005).
50. Cohen R, Reinert P, De La Rocque R et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr. Infect. Dis. J. 21, 297-303 (2002).